Phase II Study of Cisplatin plus Cetuximab in Advanced, Recurrent, and Previously Treated Cancers of the Cervix and Evaluation of Epidermal Growth Factor Receptor Immunohistochemical Expression: A Gynecologic Oncology Group Study

BACKGROUND: The purpose of this study was to evaluate the safety and efficacy of cetuximab (C225), an antibody that inhibits epidermal growth factor receptor (EGFR) activity, with cisplatin and to explore associations between EGFR protein expression with patient demographics or clinical outcome. MET...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Farley, John, Sill, Michael W., Birrer, Michael, Walker, Joan, Schilder, Russell J., Thigpen, J. Tate, Coleman, Robert L, Miller, Brigitte E., Rose, Peter G., Lankes, Heather A.
格式: Artigo
語言:Inglês
出版: 2011
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3081894/
https://ncbi.nlm.nih.gov/pubmed/21329967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.01.030
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍